ALK and anaplastic large cell lymphoma: Studies in Anaplastic Large Cell Lymphoma (ALCL) report that miR-135b is involved in anaplastic nucleophosmin-lymphoma kinase-mediated oncogenicity (NPM-ALK) and potentiates the IL-17-producing immunophenotype [130].